Predicting the sensitizing potency of trichloroethylene by in vitro test
10.11763/j.issn.2095-2619.2018.03.002
- Author:
Lihai ZENG
1
;
Jiewei ZHENG
1
;
Zhiwei XIE
1
;
Yizhou ZHONG
1
;
Guoliang LI
1
;
Boxuan LIANG
1
;
Xiao YIN
1
;
Guanchao LAI
1
;
Zhenlie HUANG
1
Author Information
1. Guangdong Province Hospital for Occupational Diseases Prevention and Treatment,Guangdong Provincial Key Laboratory of Occupational Disease Prevention and Treatment Guangzhou,Guangdong 510300,China
- Publication Type:Journal Article
- Keywords:
Trichloroethylene;
Skin sensitization;
THP-1 cell;
In vitro test;
Cluster of differentiation
- From:
China Occupational Medicine
2018;45(03):279-284
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE: To predict the sensitizing potency and optimal sensitization dose of trichloroethylene( TCE) by an in vitro skin sensitization test on a human acute monocytosis cell line( THP-1).METHODS: THP-1 cells were cultured in vitro and exposed to 2,4-dinitrochlorobenzene( DNCB),sodium dodecyl sulfate( SDS),tert-butylhydroquinone( tBHQ)and TCE for 24 hours.Flow cytometry was used to detect the expression of cell surface marker such as cluster of differentiation( CD) 86 and CD54,and the optimal dose range for sensitization detection was determined.With the relative fluorescence intensity( RFI),CD86 ≥ 150 and CD54 ≥ 200 as the standard,the sensitizing potency and optimal sensitization dose of TCE were predicted.RESULTS: The concentration range of reagents for sensitization test on THP-1 cells was the dose range at which the relative cell survival rate reached 75.0%-100.0%.DNCB at the doses of 20.83,25.00 and 30.00 μmol/L,tBHQ at the dose of 5.80 μmol/L,TCE at the doses of 8.33,10.00 and 12.00 mmol/L,can cause sensitivity.SDS was recognized as a negative sensitizer.The expression of CD86 and CD54 was the highest when the concentration of TCE was 8.33 mmol/L,which was considered as the best sensitization dose.CONCLUSION: The optimum sensitization dose of TCE is 8.33 mmol/L,which can provide the basis for dose design in future study of TCE sensitization pathways.
